Background And Objectives: Concern about diversion of buprenorphine/naloxone (B/N) in the United States may affect prescribing patterns and policy decisions. This study examines addiction treatment clinician beliefs and attitudes regarding B/N diversion.
Methods: Participants (n = 369) completed a 34-item survey in 2010 during two national symposia on opioid dependence.